16373716 |
Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val654Ala
McLean, SR,
Boshoff, C,
Hartzoulakis, B,
Gana-Weisz, M,
Frow, R,
Whelan, J,
Selwood, D
|
Mol. Cancer Ther. |
2005 |
22089421 |
Gastrointestinal stromal tumours: origin and molecular oncology
Barnett, CM,
Corless, CL,
Heinrich, MC
|
Nat. Rev. Cancer |
2011 |
17193819 |
Gastrointestinal stromal tumor (GIST) pathogenesis, familial GIST, and animal models
Antonescu, CR
|
Semin Diagn Pathol |
2006 |
29704617 |
The role of small molecule Kit protein-tyrosine kinase inhibitors in the treatment of neoplastic disorders
Roskoski, R
|
Pharmacol. Res. |
2018 |
7513208 |
Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation
Kitamura, Y,
Kanakura, Y,
Matsuzawa, Y,
Isozaki, K,
Morimoto, M,
Nomura, S,
Furitsu, T,
Tsujimura, T
|
Blood |
1994 |
30707374 |
KIT as an Oncogenic Driver in Melanoma: An Update on Clinical Development
Carvajal, RD,
Meng, D
|
Am J Clin Dermatol |
2019 |
30792533 |
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
Heinrich, MC,
Ketzer, J,
Bauer, S,
Zhu, M,
Presnell, A,
Raut, CP,
George, S,
Mannan, AM,
Serrano, C,
Yu, C,
Sicinska, E,
Tao, DL,
Rubin, BP,
Fletcher, JA,
Mariño-Enríquez, A,
Demetri, GD,
Eilers, G,
Czaplinski, JT,
McKinley, A
|
Br. J. Cancer |
2019 |
15342366 |
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors
Raymond, AK,
Choi, H,
Frazier, ML,
Wu, EF,
Feig, BW,
Hittelman, W,
Ramdas, L,
Velasco, MA,
Patel, S,
Oyedeji, CO,
Pollock, RE,
Prieto, VG,
Benjamin, RS,
Zhang, W,
Burgess, MA,
Hayes, KJ,
Trent, JC,
Chen, LL,
Macapinlac, HA,
Hunt, KK,
Fuller, GN
|
Cancer Res. |
2004 |
9438854 |
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
Kitamura, Y,
Muhammad Tunio, G,
Kanakura, Y,
Matsuzawa, Y,
Hanada, M,
Moriyama, Y,
Isozaki, K,
Nishida, T,
Hashimoto, K,
Ishiguro, S,
Kawano, K,
Takeda, M,
Kurata, A,
Hirota, S,
Shinomura, Y
|
Science |
1998 |
7691885 |
Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product
Kitamura, Y,
Kanakura, Y,
Kanayama, Y,
Matsuzawa, Y,
Sugahara, H,
Tono, T,
Tsujimura, T,
Butterfield, JH,
Koshimizu, U,
Ashman, LK,
Kitayama, H,
Furitsu, T,
Ikeda, H
|
J. Clin. Invest. |
1993 |
7479840 |
Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder
Nagata, H,
Chowdhury, BA,
Metcalfe, DD,
Suzuki, Y,
Worobec, AS,
Tannenbaum, S,
Oh, CK
|
Proc. Natl. Acad. Sci. U.S.A. |
1995 |
16751810 |
Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients
Greco, A,
Carbone, A,
Ferrone, M,
Pilotti, S,
Casali, PG,
Negri, T,
Fermeglia, M,
Lagonigro, MS,
Gronchi, A,
Pricl, S,
Miselli, F,
Tamborini, E,
Pierotti, MA
|
Oncogene |
2006 |
11378569 |
Activating mutations of c-kit at codon 816 confer drug resistance in human leukemia cells
Arceci, RJ,
Ning, ZQ,
Li, J
|
Leuk. Lymphoma |
2001 |
10362788 |
Activating c-kit gene mutations in human germ cell tumors
Tian, Q,
Krystal, GW,
Moskaluk, CA,
Frierson, HF
|
Am. J. Pathol. |
1999 |
19164557 |
KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients
Quenzer, T,
Emmett, MR,
Deshmukh, GD,
Lunney, EA,
English, JM,
Wu, JC,
Christensen, J,
Molina, D,
He, YA,
Zhang, Y,
Greig, MJ,
Demetri, GD,
Yu, X,
Diehl, W,
McTigue, M,
Gajiwala, KS,
DiNitto, JP,
Wells, PA,
Jacques, SL,
Zou, A,
Zhang, HM,
Marshall, AG
|
Proc. Natl. Acad. Sci. U.S.A. |
2009 |
8589724 |
Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm
Lu, SZ,
Jacobs, P,
Modlin, I,
Ding, TG,
Ma, YS,
Tang, LH,
Longley, BJ,
Duffy, T,
Tyrrell, L,
Langley, K
|
Nat. Genet. |
1996 |
10660321 |
C-kit mutations in core binding factor leukemias
Beghini, A,
Larizza, L,
Peterlongo, P,
Cairoli, R,
Mecucci, C,
Morra, E,
Ripamonti, CB
|
Blood |
2000 |
9990072 |
Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis
Ma, Y,
Metcalfe, DD,
Lu, SZ,
Wang, X,
Heitjan, D,
Longley, BJ,
Tyrrell, L,
Tharp, M
|
Proc. Natl. Acad. Sci. U.S.A. |
1999 |
30792534 |
Secondary KIT mutations: the GIST of drug resistance and sensitivity
Napolitano, A,
Vincenzi, B
|
Br. J. Cancer |
2019 |